Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic necrotizing vasculitis

W L Gross1

  • 1Department of Rheumatology, University of Lübeck, Rheumaklinik Bad Bramstedt.

Bailliere'S Clinical Rheumatology
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Anti-neutrophil cytoplasmic antibodies (ANCA) revived interest in systemic necrotizing vasculitis. This review details ANCA-associated vasculitides, comparing standard treatments with new regimens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Der Internist·2016
Same author

[Future integrated health care in internal medicine: primary hypertension and polyangiitis with granulomatosis as modell diseases].

Deutsche medizinische Wochenschrift (1946)·2015
Same author

[Genetic architecture of chronic inflammatory diseases].

Der Internist·2014
Same author

[Genetic risk factors for vasculitis].

Der Internist·2013
Same author

Genetics of toll like receptor 9 in ANCA associated vasculitides.

Annals of the rheumatic diseases·2013
Same author

[Hypereosinophilic syndrome].

Der Internist·2013
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Area of Science:

  • Immunology
  • Rheumatology
  • Nephrology

Background:

  • Systemic necrotizing vasculitis interest revived due to anti-neutrophil cytoplasmic antibodies (ANCA) discovery.
  • Specific ANCA subspecificities link to Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome, defining ANCA-associated vasculitides.
  • The family of ANCA-associated vasculitides is expanding with increased ANCA testing.

Purpose of the Study:

  • To describe common and divergent clinical and immunological features of ANCA-associated vasculitides.
  • To compare standard treatments (cyclophosphamide and glucocorticosteroids) with novel therapeutic strategies.
  • To provide an updated overview of this evolving group of diseases.

Main Methods:

  • Review of clinical and immunological features of ANCA-associated vasculitides.

Related Experiment Videos

  • Comparison of established and emerging treatment regimens.
  • Analysis of the impact of ANCA testing on disease classification and management.

    • Main Results:

    • Detailed characterization of distinct ANCA-associated vasculitides.
    • Identification of commonalities and differences in clinical presentation and serological markers.
    • Evaluation of treatment efficacy and adaptation based on disease stage and activity.

    Conclusions:

    • ANCA are crucial diagnostic and classification markers for systemic necrotizing vasculitis.
    • Tailored therapeutic approaches are emerging for ANCA-associated vasculitides.
    • Continued research is needed to refine treatment strategies and understand disease pathogenesis.